GEN: Light Within the Black Hole of Concussion Therapeutics
Our co-founder and chief scientific officer was recently interviewed by GEN for an article entitled, "Light Within the Black Hole of Concussion Therapies.” He talks about Oxeia’s planned Phase IIb clinical trial planned for later this year